Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Myomo, Inc. (MYO : AMEX)
 
 • Company Description   
Myomo, Inc. is a commercial stage medical robotics company. It offers expanded mobility which suffering from neurological disorders and upper limb paralysis. The company develops and markets the MyoPro(R) product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals. Myomo, Inc. is headquartered in Cambridge,Massachusetts.

Number of Employees: 185

 
 • Price / Volume Information   
Yesterday's Closing Price: $2.08 Daily Weekly Monthly
20 Day Moving Average: 718,228 shares
Shares Outstanding: 35.98 (millions)
Market Capitalization: $74.84 (millions)
Beta: 1.39
52 Week High: $7.17
52 Week Low: $2.02
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -25.71% -28.26%
12 Week -52.40% -59.83%
Year To Date -67.70% -68.15%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
45 Blue Sky Dr. Suite 101
-
Burlington,MA 01803
USA
ph: 617-996-9058
fax: -
ir@myomo.com http://www.myomo.com
 
 • General Corporate Information   
Officers
Paul R. Gudonis - Chief Executive Officer and Chairman
David A. Henry - Chief Financial Officer
Amy Knapp - Director
Thomas A. Crowley, Jr. - Director
Thomas F. Kirk - Director

Peer Information
Myomo, Inc. (BJCT)
Myomo, Inc. (CADMQ)
Myomo, Inc. (APNO)
Myomo, Inc. (UPDC)
Myomo, Inc. (IMTIQ)
Myomo, Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 62857J201
SIC: 3842
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/05/25
Share - Related Items
Shares Outstanding: 35.98
Most Recent Split Date: 1.00 (0.03:1)
Beta: 1.39
Market Capitalization: $74.84 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.04 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.16 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/05/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 3.45
Price/Cash Flow: -
Price / Sales: 1.94
EPS Growth
vs. Year Ago Period: 20.00%
vs. Previous Quarter: -700.00%
Sales Growth
vs. Year Ago Period: 161.91%
vs. Previous Quarter: -18.54%
ROE
06/30/25 - -
03/31/25 - -35.57
12/31/24 - -45.32
ROA
06/30/25 - -
03/31/25 - -20.11
12/31/24 - -27.10
Current Ratio
06/30/25 - -
03/31/25 - 2.66
12/31/24 - 3.22
Quick Ratio
06/30/25 - -
03/31/25 - 2.37
12/31/24 - 2.91
Operating Margin
06/30/25 - -
03/31/25 - -15.05
12/31/24 - -19.00
Net Margin
06/30/25 - -
03/31/25 - -15.05
12/31/24 - -19.00
Pre-Tax Margin
06/30/25 - -
03/31/25 - -13.96
12/31/24 - -17.87
Book Value
06/30/25 - -
03/31/25 - 0.60
12/31/24 - 0.82
Inventory Turnover
06/30/25 - -
03/31/25 - 3.56
12/31/24 - 3.25
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
Debt-to-Capital
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
 

Powered by Zacks Investment Research ©